Use of aspirin for the manufacture of a medicament for implanting an embryo into the uterine endometrium
US6100249A · kind A · utility
4Cited by
1References
2Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 5, 1997 |
| Grant date | Aug 8, 2000 |
| Priority date | — |
| Expiry date | Dec 5, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides the use of a cycloaygenase inhibitor such as the non-steroidal anti-inflammatory agent aspirin in the manufacture of a medicament to enhance perfusion of blood through the mammalian, preferably human, uterus. The enhanced perfusion aids implantation in natural or assisted methods of conception
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.